ACR GUIDELINES Bundle (free trial)

Periop ACR

American College of Rheumatology GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1512446

Contents of this Issue

Navigation

Page 3 of 7

Table 2. Medications to WITHHOLD Prior To Surgery** BIOLOGICS: WITHHOLD these medications through surgery Dosing Interval Recommended timing of surgery since last medication dose Infliximab (Remicade) Every 4, 6, or 8 weeks Week 5, 7, or 9 Adalimumab (Humira) Every 2 weeks Week 3 Etanercept (Enbrel) Every week Week 2 Abatacept (Orencia) Monthly (IV) or weekly (SQ) Week 5 Week 2 Certolizumab (Cimzia) Every 2 or 4 weeks Week 3 or 5 Rituximab (Rituxan) 2 doses 2 weeks apart every 4–6 months Month 7 Tocilizumab (Actemra) Every week (SQ) or every 4 weeks (IV) Week 2 Week 5 Anakinra (Kineret) Daily Day 2 IL-17-Secukinumab (Cosentyx) Every 4 weeks Week 5 Ustekinumab (Stelara) Every 12 weeks Week 13 Ixekizumab (Taltz) † Every 4 weeks Week 5 IL-23 Guselkumab (Tremfya) † Every 8 weeks Week 9 JAK inhibitors: WITHHOLD this medication 3 days prior to surgery* Tofacitinib (Xeljanz) Daily or twice daily Day 4 Baricitinib (Olumiant) † Daily Day 4 Upadacitinib (Rinvoq) † Daily Day 4

Articles in this issue

Archives of this issue

view archives of ACR GUIDELINES Bundle (free trial) - Periop ACR